Raymond James & Associates Emergent Bio Solutions Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$27.42 - $43.63 $9,021 - $14,354	329 Added 1.55%	21,538 $669,000
Q1 2022 May 11, 2022	BUY	$36.48 - $52.22 $155,331 - $222,352	4,258 Added 25.12%	21,209 $871,000
Q4 2021 Feb 08, 2022	SELL	$33.11 - $55.01 $67,411 - $112,000	-2,036 Reduced 10.72%	16,951 $737,000
Q3 2021 Nov 02, 2021	BUY	$50.07 - $66.05 $66,643 - $87,912	1,331 Added 7.54%	18,987 $951,000
Q2 2021 Aug 11, 2021	SELL	$56.61 - $80.46 $772,217 - $1.1 Million	-13,641 Reduced 43.59%	17,656 $1.11 Million
Q1 2021 May 14, 2021	BUY	$86.23 - $125.19 $955,514 - $1.39 Million	11,081 Added 54.81%	31,297 $2.91 Million
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $77,586 - $109,240	980 Added 5.09%	20,216 $1.81 Million
Q3 2020 Nov 04, 2020	BUY	$81.91 - $134.94 $184,051 - $303,210	2,247 Added 13.23%	19,236 $1.99 Million
Q2 2020 Jul 28, 2020	BUY	$54.33 - $89.52 $252,851 - $416,626	4,654 Added 37.73%	16,989 $1.34 Million
Q1 2020 Apr 21, 2020	BUY	$49.34 - $68.76 $608,608 - $848,154	12,335 New	12,335 $714,000
Q4 2019 Feb 12, 2020	SELL	$51.21 - $59.06 $241,608 - $278,645	-4,718 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$40.6 - $57.2 $191,550 - $269,869	4,718 New	4,718 $247,000
Q2 2019 Aug 06, 2019	SELL	$39.92 - $53.86 $362,513 - $489,102	-9,081 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$48.23 - $66.16 $100,029 - $137,215	-2,074 Reduced 18.59%	9,081 $459,000
Q4 2018 Feb 11, 2019	BUY	$55.63 - $73.24 $23,142 - $30,467	416 Added 3.87%	11,155 $661,000
Q3 2018 Nov 14, 2018	BUY	$52.05 - $66.51 $16,499 - $21,083	317 Added 3.04%	10,739 $707,000
Q2 2018 Aug 14, 2018	SELL	$48.33 - $55.64 $18,075 - $20,809	-374 Reduced 3.46%	10,422 $526,000
Q1 2018 May 14, 2018	BUY	$44.44 - $54.39 $139,363 - $170,567	3,136 Added 40.94%	10,796 $568,000
Q3 2017 Nov 13, 2017	SELL	$34.14 - $40.45 $14,133 - $16,746	-414 Reduced 5.13%	7,660 $310,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,074	8,074 $274,000

Others Institutions Holding EBS

# of Institutions

159

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$36.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$32.2 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$23.6 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$21.1 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$18.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account